| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 13,680 | $30 | $465K |
| J9312 | Injection, rituximab, 10 mg | 5,550 | $60 | $355.2K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 22,120 | $10 | $221.2K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 24,150 | $10 | $193.2K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 42,800 | $1 | $171.2K |
| J0897 | Injection, denosumab, 1 mg | 9,000 | $20 | $162K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,090 | $90 | $102.6K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 1,160 | $50 | $53.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,720 | $30 | $46.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 680 | $60 | $37.6K |